Cargando…
The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis
INTRODUCTION: Approximately 5% of primary breast cancer patients present de novo stage IV breast cancer, for whom systematic therapy is the mainstream treatment. The role of surgical excision of the primary tumor has been controversial due to inconsistent results of relevant studies. Recently, with...
Autores principales: | Lu, Shuangshuang, Wu, Jiayi, Fang, Yan, Wang, Wei, Zong, Yu, Chen, Xiaosong, Huang, Ou, He, Jian-Rong, Chen, Weiguo, Li, Yafen, Shen, Kunwei, Zhu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837759/ https://www.ncbi.nlm.nih.gov/pubmed/29545938 http://dx.doi.org/10.18632/oncotarget.23189 |
Ejemplares similares
-
Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer
por: Wu, Jiayi, et al.
Publicado: (2014) -
Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer: a meta-analysis
por: Qi, Xin-Yu, et al.
Publicado: (2019) -
Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective Study
por: Huang, Jiahui, et al.
Publicado: (2019) -
Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample
por: Zhu, Siji, et al.
Publicado: (2019) -
Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast Cancer
por: Li, Shuai, et al.
Publicado: (2022)